Why the study?
The maximum dose of continuous mivacurium infusion for intraoperative neuromonitoring and its adverse reactions during thyroid surgery under total intravenous anesthesia were investigated.
What is the maximum dose of continuous mivacurium infusion for intraoperative neuromonitoring during thyroid surgery under TIVA?
What is the maximum dose of continuous mivacurium infusion for intraoperative neuromonitoring during thyroid surgery under TIVA?
Continuous mivacurium infusion can be used during thyroid surgery under TIVA without affecting intraoperative neuromonitoring or causing serious adverse reactions.
Answers are grounded in this paper and cite their sources.
Continuous mivacurium infusion appears feasible for IONM under TIVA; leaves open optimal dosing and safety confirmation in prospective trials.
OBJECTIVE: To investigate the maximum dose of continuous mivacurium infusion for intraoperative neuromonitoring (IONM) and observe the adverse reactions during thyroid surgery under total intravenous anesthesia (TIVA). METHODS: ) after initiation of intraoperative infusion of the muscle relaxant. RESULTS: ) during thyroid surgery under TIVA. One patient (3.3%) developed transient facial skin redness after induction. Intubation difficulties or body motions occurred in none of the patients during the surgery. Pair-wise comparison showed no significant variations in MAP or HR of the patients at the 5 time points (P>0.05). CONCLUSIONS: ), which does not affect IONM or causes serious adverse reactions during the operation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: